http://www.zynerba.com
Zynerba Pharmaceuticals, Inc. Company Intro
Advancing Science. Improving Connections. Next-generation transdermal cannabinoid therapeutics to improve the lives of patients affected by rare and near-rare neuropsychiatric conditions.
Industry
Healthcare
Zynerba Pharmaceuticals, Inc. Headquaters
80 West Lancaster Avenue
Devon,19333
United States
Zynerba Pharmaceuticals, Inc. Share price
17 May 2023 14:09 GMT
$0.3210
-0.01 (-3.02 %)
Zynerba Pharmaceuticals, Inc. Market cap
$17.898 M
WMC RANKING
2024
Zynerba Pharmaceuticals, Inc. # 86
Drug Manufacturers—Specialty & GenericLatest Zynerba Pharmaceuticals, Inc. News
12 Feb 2024
Autism Spectrum Disorders Treatment Market Size and Global Forecast 2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
12 Feb 2024
Behavioral Rehabilitation Market to Reach $316.1 Billion by 2028, Growing at a 5.9% Rate
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
13 Feb 2024
Autism Spectrum Disorder Therapeutics Market Unlocking Potential: Navigating Growth in Trends and Forecast by
Press release - Coherent Market Insights - Autism Spectrum Disorder Therapeutics Market Unlocking Potential: Navigating Growth in Trends and Forecast by...
WMC Market Score
WMC Market to Revenue Score
Zynerba Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Zynerba Pharmaceuticals, Inc. | USD | $0 | $49,148 | $-46,961 | $179M | 86 |
| Teva Pharmaceutical Industries Limited | USD | $16,283,000 | $4,659,000 | $-3,982,000 | $91,050B | 1 |
| Bausch Health Companies Inc. | USD | $8,042,000 | $4,348,001 | $-1,018,000 | $21,900B | 2 |
| Zoetis Inc. | USD | $7,012,000 | $2,380,000 | $1,774,000 | $826,670B | 3 |
| Perrigo Company plc | USD | $4,990,000 | $1,357,500 | $-230,900 | $44,310B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Zynerba Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Zynerba Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Zynerba Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Zynerba Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Zynerba Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Zynerba Pharmaceuticals, Inc. | 0 | 0.11 | 0.01 | 0 | 0 | 0 | 0.04 |
| Teva Pharmaceutical Industries Limited | 100 | 3.55 | 2.31 | 55 | 0 | 0 | 20.74 |
| Bausch Health Companies Inc. | 49.39 | 1.02 | 47.07 | 91 | 0 | 0 | 47.76 |
| Zoetis Inc. | 43.06 | 100 | 100 | 92 | 0 | 0 | 100 |
| Perrigo Company plc | 30.65 | 4.61 | 3.01 | 100 | 0 | 0 | 36.89 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
